Skip to content

Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid TL (REF 043.260S)Recalls & reported problems

Institut Straumann AG · Standard Plus Implant, D 3.3mm RN, SLA® 8mm, Roxolid®, Loxim™ · Class 2 · Implant

Quick summary

This Straumann Roxolid SLA dental implant is placed in the jawbone. Reports most often describe the implant failing to fuse with the bone, and some mention scar-like tissue, pain, tissue damage and infection. The device appears in 4,726 reports, with 4,726 injuries and no deaths. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
4,744
Deaths reported
0
Injuries reported
4,744
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4,744 adverse event reports that list this exact device (DI 07630031718976), received between Aug 28, 2019 and Sep 28, 2026 — classified as 4,744 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (3,051 reports).

2 other recalls cover devices cleared under the same FDA submission (K150938); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 33 reportsDec 2023: 51 reportsJan 2024: 41 reportsFeb 2024: 59 reportsMar 2024: 56 reportsApr 2024: 79 reportsMay 2024: 43 reportsJun 2024: 70 reportsJul 2024: 63 reportsAug 2024: 69 reportsSep 2024: 48 reportsOct 2024: 110 reportsNov 2024: 95 reportsDec 2024: 41 reportsJan 2025: 42 reportsFeb 2025: 57 reportsMar 2025: 46 reportsApr 2025: 35 reportsMay 2025: 0 reportsJun 2025: 162 reportsJul 2025: 66 reportsAug 2025: 39 reportsSep 2025: 28 reportsOct 2025: 56 reportsNov 2025: 56 reportsDec 2025: 64 reportsJan 2026: 52 reportsFeb 2026: 55 reportsMar 2026: 74 reportsApr 2026: 41 reportsMay 2026: 60 reportsJun 2026: 48 reportsJul 2026: 54 reportsAug 2026: 33 reportsSep 2026: 25 reportsOct 2026: 0 reports202420252026162
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate3,051
  • Loss of Osseointegration1,406
  • Fracture184
  • Adverse Event Without Identified Device or Use Problem103
  • Difficult to Insert13
  • Unintended Movement5
  • Unstable5
  • Difficult to Remove3

Patient problems

  • No Clinical Signs, Symptoms or Conditions1,945
  • Fibrosis1,540
  • Pain1,030
  • Tissue Damage610
  • Unspecified Infection591
  • Hemorrhage/Blood Loss/Bleeding277
  • Inflammation225
  • Swelling/ Edema150

Recent adverse event reports

The 25 most recent of 4,744 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 50921582 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50921155 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 50920064 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50919899 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2025 in ADA 13. On (b)(6) 2026, loss of osseointegration was verified. Patient presented with bone type IV and inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50918449 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50825838 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50825160 ↗
  • InjurySep 17, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 44. On (b)(6) 2026, loss of osseointegration was verified. Patient presented with bone type III. The device was forwarded to the manufacturer. At the event the patient experienced: Peri-implantitis and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 50806882 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Pain

    MAUDE report 50760782 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Pain

    MAUDE report 50760780 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760698 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Pain

    MAUDE report 50760330 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759675 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759336 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759309 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 46. On (b)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Pain and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Pain

    MAUDE report 50759075 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Hypersensitivity/Allergic reaction; Pain; Unspecified Infection

    MAUDE report 50758551 ↗
  • InjurySep 11, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50739088 ↗
  • InjurySep 11, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50738301 ↗
  • InjurySep 11, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50738295 ↗
  • InjurySep 11, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50738244 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50720120 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50718996 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50718989 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2025 in the patient's mouth. On (B)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50718985 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K150938. One submission often covers many models, so check the product and lot details in each record.

  • Z-2535-2016 · Jul 14, 2016 · Terminated
    Straumann Bone Level Implant, 4.1mm RC, SLA 12mm, TiZr, NTP Article Number: 021.4512
  • Z-2534-2016 · Jul 14, 2016 · Terminated
    Straumann Bone Level Implant, 4.1mm RC, SLA 10mm, TiZr, NTP Article Number: 021.4510

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.